Previous studies highlighted some circulating plasma biomarkers for ILD prognosis, such as CXCL13, CA-125, MMP7, SP-D, YKL-40 and VCAM-1, all of which are proteins associated with inflammation and interstitial remolding [21]. This evidence concerns the gene CXCL13 and interstitial lung disease.